DBCO-SS-paclitaxel

DBCO-SS-paclitaxel/Dibenzocyclooctyne-SS-paclitaxel/Dibenzocyclooctyne-S-S-paclitaxel/DBCO-S-S-paclitaxel is possible to form a prodrug or a drug delivery system. The DBCO group allows for site-specific attachment to azide-functionalized molecules or surfaces, facilitating targeted drug delivery. The disulfide linker can be cleaved under appropriate conditions, allowing for controlled release of the active paclitaxel drug at its site of action. This conjugate can offer advantages such as improved drug stability, enhanced selectivity, and reduced off-target effects, making it a promising approach in the development of targeted chemotherapy strategies.

msds of DBCO-SS-paclitaxel